Food and Drug Administration (FDA) approved Novo Nordisk's Wegovy pill as the first and only oral GLP-1 therapy indicated to reduce excess body weight, support long-term weight maintenance, and reduce the risk of certain major adverse cardiovascular events.1 FDA approval of the Wegovy pill was supported by a 64-week Phase 3 trial showing weight loss efficacy unmatched by other oral GLP-1 candidates, with once-daily treatment plus diet and exercise achieving 16.6% mean weight loss versus 2.7% with placebo.2 The availability of an oral formulation is expected to broaden access to GLP1 treatment by offering an alternative option for patients who may be hesitant to initiate or continue weekly injections
Romero-Corral et al., 2010
That previous over-stretch frequently results in thinner skin, with less collagen and elastin fibers, and can generate thicker, rougher, or drier patches, like on the soles of the feet and other pressure points
Over-the-Counter Semaglutide Options Over-the-counter (OTC) semaglutide alternatives are available, but research on the safety and effectiveness of these treatments is limited
Key Features of Ipamorelin: Ipamorelin is one of the newest and safest GH secretagogues
Your provider will screen you for any underlying digestive issues that could be making your symptoms worse, and theyll adjust and tailor your medications for better symptom control
